BridgeBio Pharma Inc (BBIO)
29.45
+0.60
(+2.08%)
USD |
NASDAQ |
Jan 08, 16:00
29.45
0.00 (0.00%)
Pre-Market: 20:00
BridgeBio Pharma Enterprise Value: 7.030B for Jan. 8, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Pfizer Inc | 209.15B |
Alnylam Pharmaceuticals Inc | 29.27B |
Cassava Sciences Inc | -13.07M |
Regeneron Pharmaceuticals Inc | 72.80B |
Biomarin Pharmaceutical Inc | 12.70B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -162.04M |
Revenue (Quarterly) | 2.732M |
Total Expenses (Quarterly) | 189.86M |
EPS Diluted (Quarterly) | -0.86 |
Gross Profit Margin (Quarterly) | 78.11% |
Profit Margin (Quarterly) | -5.93K% |
Earnings Yield | -8.18% |
Normalized Earnings Yield | -11.12 |